scholarly journals Pharmacologically Active Saikosaponin inBupleurum falcatumDetected by Competitive ELISA and Eastern Blotting Using Monoclonal Antibodies

2008 ◽  
Vol 11 (2) ◽  
pp. 192-197 ◽  
Author(s):  
Tae Kwon Shon ◽  
Shu-hang Zhu ◽  
Sang Chul Lee ◽  
Yukihiro Shoyama ◽  
Hiroyuki Tanaka
2017 ◽  
Vol 9 (4) ◽  
pp. 625-633 ◽  
Author(s):  
Shuchen Liu ◽  
Yue Zhang ◽  
Baoping Qu ◽  
Gaofeng Qin ◽  
Jinjun Cheng ◽  
...  

We investigated a newly developed indirect competitive enzyme-linked immunosorbent assay for the determination of 5 major components of TBA, which works efficiently in different types of biological samples, and may be suitable for routine clinical practice.


1993 ◽  
Vol 5 (4) ◽  
pp. 187-197 ◽  
Author(s):  
William T. Jones ◽  
Dawn Harvey ◽  
Stephen D. Jones ◽  
Simon Fielder ◽  
Phillip Debnam ◽  
...  

2010 ◽  
Vol 5 (s1) ◽  
pp. e150-e150
Author(s):  
Daniel Dlugolenski ◽  
Rüdiger Hauck ◽  
Robert J. Hogan ◽  
Frank Michel ◽  
Egbert Mundt

Toxins ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 383
Author(s):  
Yanan Wang ◽  
Xiaofei Wang ◽  
Haitang Zhang ◽  
Hanna Fotina ◽  
Jinqing Jiang

This study aimed to detect and monitor total Zearalenone (ZEN) and its five homologs (ZENs) in cereals and feed. The monoclonal antibodies (mAbs) with a high affinity and broad class specificity against ZENs were prepared, and the conditions of a heterologous indirect competitive ELISA (icELISA) were preliminarily optimized based on the ZEN mAbs. The immunogen ZEN-BSA was synthesized using the oxime active ester method (OAE) and identified using infrared (IR) and ultraviolet (UV). The coating antigen ZEN-OVA was obtained via the 1,4-butanediol diglycidyl ether method (BDE). Balb/c mice were immunized using a high ZEN-BSA dose with long intervals and at multiple sites. A heterologous indirect non-competitive ELISA (inELISA) and an icELISA were used to screen the suitable cell fusion mice and positive hybridoma cell lines. The ZEN mAbs were prepared by inducing ascites in vivo. The standard curve was established, and the sensitivity and specificity of the ZEN mAbs were determined under the optimized icELISA conditions. ZEN-BSA was successfully synthesized at a conjugation ratio of 17.2:1 (ZEN: BSA). Three hybridoma cell lines, 2D7, 3C2, and 4A10, were filtered, and their mAbs corresponded to an IgG1 isotype with a κ light chain. The mAbs titers were between (2.56 to 5.12) × 102 in supernatants and (1.28 to 5.12) × 105 in the ascites. Besides, the 50% inhibitive concentration (IC50) values were from 18.65 to 31.92 μg/L in the supernatants and 18.12 to 31.46 μg/L in the ascites. The affinity constant (Ka) of all of the mAbs was between 4.15 × 109 and 6.54 × 109 L/mol. The IC50 values of mAb 2D7 for ZEN, α-ZEL, β-ZEL, α-ZAL, β-ZAL and ZAN were 17.23, 16.71, 18.27, 16.39, 20.36 and 15.01 μg/L, and their cross-reactivities (CRs, %) were 100%, 103.11%, 94.31%, 105.13%, 84.63%, and 114.79%, respectively, under the optimized icELISA conditions. The limit of detection (LOD) for ZEN was 0.64 μg/L, and its linear working range was between 1.03 and 288.55 μg/L. The mAbs preparation and the optimization of icELISA conditions promote the potential development of a rapid test ELISA kit, providing an alternative method for detecting ZEN and its homologs in cereals and feed.


Antibodies ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 43
Author(s):  
Yukihiro Shoyama

An immunoblotting system (“eastern blotting”) was developed for small-molecule herbal medicines like glycosides, with no conjugation function to the membrane. Briefly, the crude extracts of herb medicines were developed by thin-layer chromatography (TLC). The small-molecule herbal medicines on TLC plates were transferred to polyvinylidene fluoride (PVDF) or polyethersulfone (PES) membranes by heating. Antigen components were divided into two categories based on their function, i.e., their membrane recognizing (aglycone part) and fixing (sugar moiety) abilities. This procedure allows for the staining of only target glycosides. Double eastern blotting was developed as a further staining system for two herb medicines using a set of MAbs and substrates.


2020 ◽  
Author(s):  
Mehul Makwana ◽  
Cleide Dos Santos Souza ◽  
Barry T. Pickup ◽  
Mark J. Thompson ◽  
Santosh Kumar Lomada ◽  
...  

Non-hydrolysable stable analogues of τ-pHis and π-pHis have been designed using electrostatic surface potential calculations, and subsequently synthesized. The τ-pHis and π-pHis analogues (phosphopyrazole <b>8 </b>and pyridyl amino amide <b>13</b>, respectively)<b> </b>were used as haptens to generate pHis polyclonal antibodies. <a>Both τ-pHis and π-pHis conjugates in the form of a BSA-glutaraldehyde-τ-pHis and BSA-glutaraldehyde-π-pHis</a> were synthesized and characterized by <sup>31</sup>P NMR spectroscopy. Commercially available τ-pHis (SC56-2) and π-pHis (SC1-1; SC50-3) monoclonal antibodies were used to show that the BSA-G-τ-pHis and BSA-G-π-pHis conjugates could be used to assess the selectivity of pHis antibodies in a competitive ELISA. Subsequently, the selectivity of the generated pHis antibodies generated using phosphopyrazole <b>8 </b>and pyridyl amino amide <b>13</b> as haptens was assessed by competitive ELISA against His, pSer, pThr, pTyr, τ-pHis and π-pHis. Antibodies generated using the phosphopyrazole <b>8</b> as a hapten were found to be selective for τ-pHis, and antibodies generated using the <a>pyridyl amino amide <b>13</b> </a>were found to be selective for π-pHis. Both τ- and π-pHis antibodies were shown to be effective in immunological experiments, including ELISA, western blot, and immunofluorescence. The τ-pHis antibody was also shown to be useful in the immunoprecipitation of proteins containing pHis


Sign in / Sign up

Export Citation Format

Share Document